Thermo Fisher Scientific Inc $ 284.25 0.61 (0.22%)
Volume:
759,783
Avg Vol (1m):
1,541,166
Market Cap $:
113.84 Bil
Enterprise Value $:
130.59 Bil
P/E (TTM):
32.46
P/B:
3.98
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| Peter Lynch Value | ||
| DCF (FCF Based) | ||
| DCF (Earnings Based) | ||
|
Price: $284.25 | ||
Manual of Stocks™ Web
Financial Strength | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.12 | ||
| Equity-to-Asset | 0.5 | ||
| Debt-to-Equity | 0.66 | ||
| Debt-to-EBITDA | 2.73 | ||
| Interest Coverage | 5.67 | ||
| Piotroski F-Score | 6 | ||
| Altman Z-Score | 3.6 | ||
| Beneish M-Score | -2.58 | ||
| WACC vs ROIC | |||
Profitability | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 16.05 | ||
| Net Margin % | 14.24 | ||
| ROE % | 12.89 | ||
| ROA % | 6.32 | ||
| ROC (Joel Greenblatt) % | 59.17 | ||
| 3-Year Revenue Growth Rate | 12.4 | ||
| 3-Year EBITDA Growth Rate | 15 | ||
| 3-Year EPS without NRI Growth Rate | 13.7 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 32.46 | ||
| Forward PE Ratio | 20.92 | ||
| PE Ratio without NRI | 32.46 | ||
| Price-to-Owner-Earnings | 24.04 | ||
| PB Ratio | 3.98 | ||
| PS Ratio | 4.62 | ||
| Price-to-Free-Cash-Flow | 28.19 | ||
| Price-to-Operating-Cash-Flow | 23.18 | ||
| EV-to-EBIT | 27.58 | ||
| EV-to-EBITDA | 18.7 | ||
| EV-to-Revenue | 5.25 | ||
| PEG Ratio | 2.38 | ||
| Shiller PE Ratio | 57.37 | ||
| Current Ratio | 1.49 | ||
| Quick Ratio | 1.07 | ||
| Days Inventory | 80.34 | ||
| Days Sales Outstanding | 60.6 | ||
| Days Payable | 36.79 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 0.26 | ||
| Dividend Payout Ratio | 0.08 | ||
| 3-Year Dividend Growth Rate | 4.3 | ||
| Forward Dividend Yield % | 0.27 | ||
| 5-Year Yield-on-Cost % | 0.28 | ||
| 3-Year Average Share Buyback Ratio | -0.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 1.76 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 1.77 | ||
| Price-to-Median-PS-Value | 1.53 | ||
| Price-to-Peter-Lynch-Fair-Value | 2.68 | ||
| Earnings Yield (Greenblatt) % | 3.63 | ||
| Forward Rate of Return (Yacktman) % | 14.86 |